514336 GENESIS

Genesis IBRC India Share Price

₹17.47 0.00 (0.00%)

28 Dec, 2024 17:34

SIP TrendupStart SIP in GENESIS

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 4.99%
  • Over 3 Month + 10.22%
  • Over 6 Month + 33.77%
  • Over 1 Year + 79.55%
SIP Lightning

Smart Investing Starts Here Start SIP with Genesis IBRC India for Steady Growth!

Invest Now

Genesis IBRC India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Genesis IBRC India Financials

Genesis IBRC India Technicals

EMA & SMA

Current Price
₹17.47
0 (0%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹15.27
  • 50 Day
  • ₹12.99
  • 100 Day
  • ₹11.22
  • 200 Day
  • ₹10.18

Resistance and Support

17.47 Pivot Speed
  • R3 17.47
  • R2 17.47
  • R1 17.47
  • S1 17.47
  • S2 17.47
  • S3 17.47

What's your outlook on Genesis IBRC India?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Genesis Ibrc India has an operating revenue of Rs. 4.38 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of -75% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It has recently broken out of a base in its weekly chart and is trading around 10% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 61 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genesis IBRC India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-13 Quarterly Results
2023-11-14 Quarterly Results

Genesis IBRC India F&O

Genesis IBRC India Shareholding Pattern

11.33%
49.32%
39.35%

About Genesis IBRC India

  • NSE Symbol
  • GENESIS
  • BSE Symbol
  • 514336
  • ISIN
  • INE194N01016

Similar Stocks to Genesis IBRC India

Genesis IBRC India FAQs

Genesis IBRC India share price is ₹17 As on 28 December, 2024 | 17:20

The Market Cap of Genesis IBRC India is ₹22.7 Cr As on 28 December, 2024 | 17:20

The P/E ratio of Genesis IBRC India is -141.8 As on 28 December, 2024 | 17:20

The PB ratio of Genesis IBRC India is 4.5 As on 28 December, 2024 | 17:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23